| 國立臺灣大學 |
2011 |
Wdhd1 Modulates the Post-Transcriptional Step of the Centromeric Silencing Pathway
|
謝嘉玲; 林志立; 劉軒; 史啟君; 鐘昌政; 呂勝春; 譚賢明; HSIEH, CHIA-LING; LIN, CHIH-LI; LIU, HSUAN; SHIH, CHII-JIUN; ZHONG, CHANG-ZHENG; LEE, SHENG-CHUNG; TAN, BERTRAND CHIN-MING |
| 亞洲大學 |
2010-12 |
Targeting l1 cell adhesion molecule using lentivirus-mediated short hairpin RNA interference reverses aggressiveness of oral squamous cell carcinoma
|
謝嘉玲;Hsieh, Chia-Ling |
| 亞洲大學 |
2010-11 |
A novel targeting modality for renal cell carcinoma: human osteocalcin promoter-mediated gene therapy synergistically induced by vitamin C and vitamin D
|
謝嘉玲;Hsieh, Chia-Ling |
| 中國醫藥大學 |
2010-07-31 |
探討細胞吸附分子L1在前列腺癌轉移的生物機制與治療之可行性
|
謝嘉玲 |
| 中國醫藥大學 |
2010-07-31 |
探討細胞吸附分子L1在前列腺癌轉移的生物機制與治療之可行性
|
謝嘉玲 |
| 中國醫藥大學 |
2010-04 |
間質幹細胞腫瘤趨向性之機制探討及在標靶基因治療的應用(I)
|
謝嘉玲 |
| 中國醫藥大學 |
2009-07 |
評估以ADAM9基因治療結合放射線治療對前列腺癌骨轉移之研究
|
宋賢穎; 謝嘉玲 |
| 亞洲大學 |
2008-12 |
Coevolution of Prostate Cancer and Bone Stroma in Three-Dimensional Coculture: Implications for Cancer Growth and Metastasis
|
謝嘉玲;Hsieh, Chia-Ling |
| 中國醫藥大學 |
2008-07-31 |
探討細胞吸附分子L1在前列腺癌轉移的生物機制與治療之可行性
|
謝嘉玲 |
| 中國醫藥大學 |
2008-07-31 |
探討細胞吸附分子L1在前列腺癌轉移的生物機制與治療之可行性
|
謝嘉玲 |
| 中國醫藥大學 |
2006-09 |
B2-Microglobulin Is a Signaling and Growth-Promoting Factor for Human Prostate Cancer Bone Metastasis
|
(Wen-Chin Huang); (Daqing Wu); (Zhihui Xie); (Haiyen E. Zhau); (Takeo Nomura); (Jan Pohl); 謝嘉玲; (M. Neale Weitzmann); (Mary C. Farach-Carson); (Leland W.K. Chung)* |
| 中國醫藥大學 |
2006-06 |
IGF-I Secretion by Prostate Carcinoma Cells Does not Alter Tumor-Bone Cell Interactions In Vitro or In Vivo
|
(Janet Rubin)*; (Xian Fan); (Jill Rahnert); (Buer Sen); 謝嘉玲; (Tamara C. Murphy); (Mark S. Nanes); (Lindsay G. Horton); (Wesley G. Beamer); (Clifford J. Rosen) |
| 國立臺灣大學 |
2006 |
Identification of Alpha-Enolase as an Autoantigen in Lung Cancer: Its Overexpression Is Associated with Clinical Outcomes
|
張基晟; 劉柯俊; 謝嘉玲; 陸坤泰; 許立翰; 陳姿怡; 陳焜結; 楊宗穎; 周德盈; 彭汪嘉康; CHANG, GEE-CHEN; LIU, KO-JIUNN; HSIEH, CHIA-LING; LUH, KWEN-TAY; HSU, LI-HAN; CHEN, CHIH-YI; CHEN, KUN-CHIEH; YANG, TSUNG-YING; CHOU, TEH-YI; WHANG-PENG, JACQUELINE; SHIH, NENG-YAO |
| 中國醫藥大學 |
2005-10 |
Luciferase Transgenic Mouse Model: Visualization of Prostate Development and its
|
謝嘉玲*; (Zhihui Xie); (Zi-Yao Liu); (Jeffrey E. Green); (W. David Martin); (Milton W. Datta); (Fan Yeung); (Dongfeng Pan); (Leland W.K. Chung) |
| 中國醫藥大學 |
2005-09 |
Morin sulphate/glucuronides enhance macrophage function in microgravity culture system
|
謝嘉玲; 李珮端(Pei Dawn Lee Chao); 方世華(Fang SH)* |
| 中國醫藥大學 |
2005-03 |
Cotargeting tumor and tumor endothelium effectively inhibits the growth of human prostate cancer in adenovirus-mediated antiangiogenesis and oncolysis combination therapy
|
(Jin, F); (Xie, Z); (Kuo, C. J.); (Chung, L. W.); 謝嘉玲* |
| 中國醫藥大學 |
2004-02 |
Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells
|
謝嘉玲; (Gardner, T. A.); (Miao, L.); (Balian, G.); (Chung, L. W.)* |
| 中國醫藥大學 |
2002-06 |
A novel targeting modality to enhance adenoviral replication by vitamin D(3) in androgen-independent human prostate cancer cells and tumors.
|
謝嘉玲*; (Ling Yang); (Li Miao); (Fang Yeung); (Chinghai Kao); (Hua Yang); (Haiyen E. Zhau); (Leland W. K. Chung) |
| 中國醫藥大學 |
2001-08 |
A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.
|
(Shigeji Matsubara); (Yoshitaka Wada); (Thomas A. Gardner); (Masayuki Egawa); (Moon-Soo Park); 謝嘉玲; (Haiyen E. Zhau); (Chinghai Kao); (Sadao Kamidono); (Jay Y. Gillenwater); (Leland W. K. Chung)* |
| 中國醫藥大學 |
2001 |
New prospectives of prostate cancer gene therapy: molecular targets and animal models
|
謝嘉玲; (Leland W.K. Chung) |
| 中國醫藥大學 |
2000-11 |
Induction of antitumor immunity with combination of HER2/neu DNA vaccine and interleukin 2 gene-modified tumor vaccine
|
(Shi-An Chen); (Ming-Huan Tsai); (Fu-Tien Wu); (Ali Hsiang); (Yi-Ling Chen); (Huan-Yao Lei); (Tzong-Shin Tzai); (Henry W. C. Leung); (Ying-Tai Jin); 謝嘉玲; (Lih-Hwa Hwang); (Ming-Derg Lai) |
| 中國醫藥大學 |
2000-03 |
Tumor-induced immunosuppression: a barrier to immunotherapy of large tumors by cytokine-secreting tumor vaccine
|
謝嘉玲; (Ding-Shinn Chung); (Lih-Hwa Hwang) |
| 中國醫藥大學 |
1999 |
Regression of orthotopic brain tumors by cytokine-assisted tumor vaccines primed in the brain
|
(Sheng-Hong Tseng); 謝嘉玲; (Swei-Ming Lin); (Lih-Hwa Hwang)* |
| 中國醫藥大學 |
1998-11 |
Involvement of the 5' Proximal Coding Sequences of Hepatitis C Virus with Internal Initiation of Viral Translation
|
(Lih-Hwa Hwang); 謝嘉玲; (Alan Yen); (Yi-Ling Chung)*; (Ding Shinn Chen) |
| 國立臺灣大學 |
1998 |
Involvement of the 5' Proximal Coding Sequences of Hepatitis C Virus with Internal Initiation of Viral Translation
|
黃麗華; 謝嘉玲; 嚴菁朗; 鍾宜玲; 陳定信; HWANG, LIH-HWA; HSIEH, CHIA-LING; YEN, ALAN; CHUNG, YI-LING; CHEN, DING-SHINN |
| 中國醫藥大學 |
1997-11 |
Regression of established mouse leukemia by GM-CSF-transduced tumor vaccine: implications for cytotoxic T lymphocyte responses and tumor burdens
|
謝嘉玲; (Pang, V. F); (Chen, D. S.); (Hwang, L. H)* |
| 中國醫藥大學 |
1995-09 |
Improved gene expression by a modified bicistronic retroviral vector.
|
謝嘉玲; (Bing-Fang Chen); (Chu-Chang Wang); (Hsiao-Hei Liu); (Ding-Shinn Chen); (Lih-Hwa Hwang)* |
| 中國醫藥大學 |
1992-08 |
Improved gene expression by a U3-based retroviral vector
|
(Bing-Fang Chen); 謝嘉玲; (Ding-Shinn Chen); (Lih-Hwa Hung)* |
| 中國醫藥大學 |
1992-07 |
Transient immunoglobulin M antibody response to hepatitis C virus capsid antigen in posttransfusion hepatitis C: putative serological marker for acute viral infection
|
(Chen, P. J.); (Wang, J. T); (Hwang, L. H); (Yang, Y. H.); (Yang, Y. H); 謝嘉玲; (Kao, J. H); (Sheu, J. C); (Lai, M. Y); (Wang, T. H.); (Chen, D. S)* |
